Initial clinical studies with the left ventricular assist device (LVAD) by two institutions in the United States have demonstrated that temporary assist reversed depressed cardiac function and that the concept of temporary assist is practicable. This short period of LVA probably can be done rather simply by extracorporeal devices. A plain cannulation with transaortic valvular cannulae simplifies the left ventricular assist bypass procedure by utilizing an available extracorporeal pump. With this type of system, a 2-week perfusion is realistically established. Litwak’s approach is certainly worth mentioning in this effort.